HDL Subclasses and the Distribution of Paraoxonase-1 Activity in Patients with ST-Segment Elevation Acute Myocardial Infarction

The aim of this multicentric study was to assess the impacts of oxidative stress, inflammation, and the presence of small, dense, low-density lipoproteins (sdLDL) on the antioxidative function of high-density lipoprotein (HDL) subclasses and the distribution of paraoxonase-1 (PON1) activity within HDL in patients with ST-segment elevation acute myocardial infarction (STEMI). In 69 STEMI patients and 67 healthy control subjects, the lipoproteins’ subclasses were separated using polyacrylamide gradient (3–31%) gel electrophoresis. The relative proportion of sdLDL and each HDL subclass was evaluated by measuring the areas under the peaks of densitometric scans. The distribution of the relative proportion of PON1 activity within the HDL subclasses (pPON1 within HDL) was estimated using the zymogram method. The STEMI patients had significantly lower proportions of HDL2a and HDL3a subclasses (p = 0.001 and p < 0.001, respectively) and lower pPON1 within HDL3b (p = 0.006), as well as higher proportions of HDL3b and HDL3c subclasses (p = 0.013 and p < 0.001, respectively) and higher pPON1 within HDL2 than the controls. Independent positive associations between sdLDL and pPON1 within HDL3a and between malondialdehyde (MDA) and pPON1 within HDL2b were shown in the STEMI group. The increased oxidative stress and increased proportion of sdLDL in STEMI are closely related to the compromised antioxidative function of small HDL3 particles and the altered pPON1 within HDL.

[1]  J. Kotur-Stevuljević,et al.  Overweight and obesity in polycystic ovary syndrome: association with inflammation, oxidative stress and dyslipidaemia , 2021, British Journal of Nutrition.

[2]  J. Linseisen,et al.  Association between inflammatory markers and serum paraoxonase and arylesterase activities in the general population: a cross-sectional study , 2021, Lipids in Health and Disease.

[3]  A. Stefanović,et al.  Investigation of IgG anti-oxLDL antibody levels and HDL and LDL subclasses in patients with ST-segment elevation acute myocardial infarction , 2021 .

[4]  L. Cupples,et al.  Small Dense Low‐Density Lipoprotein Cholesterol Is the Most Atherogenic Lipoprotein Parameter in the Prospective Framingham Offspring Study , 2021, Journal of the American Heart Association.

[5]  N. Wong,et al.  The Evolving Understanding and Approach to Residual Cardiovascular Risk Management , 2020, Frontiers in Cardiovascular Medicine.

[6]  K. Kotani,et al.  Paraoxonase 1, HDL Subclasses and Post Surgery Acute Inflammation: A Pilot Study , 2019, Antioxidants.

[7]  M. Najafi,et al.  The effects of oxidative stress on the development of atherosclerosis , 2019, Biological chemistry.

[8]  A. Stefanović,et al.  Activity of paraoxonase 1 (PON1) on HDL2 and HDL3 subclasses in renal disease. , 2018, Clinical biochemistry.

[9]  P. Libby,et al.  Atherosclerosis and inflammation: overview and updates. , 2018, Clinical science.

[10]  G. Norata,et al.  The Interplay of Lipids, Lipoproteins, and Immunity in Atherosclerosis , 2018, Current Atherosclerosis Reports.

[11]  P. Portincasa,et al.  Cholesterol and Lipoprotein Metabolism and Atherosclerosis: Recent Advances In reverse Cholesterol Transport. , 2017, Annals of hepatology.

[12]  X. Liao,et al.  Determination of risk factors affecting the in-hospital prognosis of patients with acute ST segment elevation myocardial infarction after percutaneous coronary intervention , 2017, BMC Cardiovascular Disorders.

[13]  A. Kontush,et al.  Antioxidative activity of high-density lipoprotein (HDL): Mechanistic insights into potential clinical benefit , 2017, BBA clinical.

[14]  M. Simionescu,et al.  Dysfunctional high-density lipoproteins have distinct composition, diminished anti-inflammatory potential and discriminate acute coronary syndrome from stable coronary artery disease patients , 2017, Scientific Reports.

[15]  E. Grapsa,et al.  Association of lipid profile with serum PON1 concentration in patients with chronic kidney disease , 2016, Renal failure.

[16]  A. Kontush,et al.  HDL particle subpopulations: Focus on biological function , 2015, BioFactors.

[17]  A. Gugliucci,et al.  Paraoxonase 1 and HDL maturation. , 2015, Clinica chimica acta; international journal of clinical chemistry.

[18]  A. Gugliucci Activation of paraoxonase 1 is associated with HDL remodeling ex vivo. , 2014, Clinica chimica acta; international journal of clinical chemistry.

[19]  P. Barter,et al.  Cardioprotective functions of HDLs1 , 2014, Journal of Lipid Research.

[20]  G. Rossi,et al.  The Role of Oxidized Low-Density Lipoproteins in Atherosclerosis: The Myths and the Facts , 2013, Mediators of inflammation.

[21]  K. Kotani,et al.  Enzymatic assessment of paraoxonase 1 activity on HDL subclasses: a practical zymogram method to assess HDL function. , 2013, Clinica chimica acta; international journal of clinical chemistry.

[22]  M. Banach,et al.  Dysfunctional HDL: a novel important diagnostic and therapeutic target in cardiovascular disease? , 2012, Progress in lipid research.

[23]  A. Kontush,et al.  Biological activities of HDL subpopulations and their relevance to cardiovascular disease. , 2011, Trends in molecular medicine.

[24]  N. Bogavac-Stanojević,et al.  LDL and HDL subclasses in acute ischemic stroke: prediction of risk and short-term mortality. , 2010, Atherosclerosis.

[25]  H. Nakazawa,et al.  Validation of the Friedewald Equation for Evaluation of Plasma LDL-Cholesterol , 2007, Journal of clinical biochemistry and nutrition.

[26]  Z. Jelić-Ivanović,et al.  LDL and HDL subclasses and their relationship with Framingham risk score in middle-aged Serbian population. , 2007, Clinical biochemistry.

[27]  B. Hansel,et al.  Defective antioxidative activity of small dense HDL3 particles in type 2 diabetes: relationship to elevated oxidative stress and hyperglycaemia , 2005, Diabetologia.

[28]  D. Rainwater,et al.  Improved method for making nondenaturing composite gradient gels for the electrophoretic separation of lipoproteins Published, JLR Papers in Press, January 16, 2004. DOI 10.1194/jlr.D300035-JLR200 , 2004, Journal of Lipid Research.

[29]  A. Kontush,et al.  Small, Dense HDL Particles Exert Potent Protection of Atherogenic LDL Against Oxidative Stress , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[30]  R. Rosenson,et al.  Myocardial injury: the acute phase response and lipoprotein metabolism. , 1993, Journal of the American College of Cardiology.

[31]  R. Krauss,et al.  Composition and distribution of low density lipoprotein fractions in hyperapobetalipoproteinemia, normolipidemia, and familial hypercholesterolemia. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[32]  A. Orekhov,et al.  Paraoxonase and atherosclerosis-related cardiovascular diseases. , 2017, Biochimie.

[33]  T. Ichida,et al.  World Medical Association declaration of Helsinki , 2008, Gastroenterologia Japonica.

[34]  E. Falk,et al.  Management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology. , 2003, European heart journal.

[35]  B. McLellan,et al.  Early measurement of systemic lipid peroxidation products in the plasma of major blunt trauma patients. , 1991, The Journal of trauma.